WO2008043533A3 - Acyl aminoimidazoles and acyl aminothiazoles - Google Patents
Acyl aminoimidazoles and acyl aminothiazoles Download PDFInfo
- Publication number
- WO2008043533A3 WO2008043533A3 PCT/EP2007/008789 EP2007008789W WO2008043533A3 WO 2008043533 A3 WO2008043533 A3 WO 2008043533A3 EP 2007008789 W EP2007008789 W EP 2007008789W WO 2008043533 A3 WO2008043533 A3 WO 2008043533A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acyl
- aminoimidazoles
- aminothiazoles
- diseases
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009531766A JP2010505896A (en) | 2006-10-11 | 2007-10-10 | Acylaminoimidazoles and acylaminothiazoles |
CA002666177A CA2666177A1 (en) | 2006-10-11 | 2007-10-10 | Acylaminoimidazoles and acylaminothiazoles |
EP07818862A EP2079708A2 (en) | 2006-10-11 | 2007-10-10 | Acyl aminoimidazoles and acyl aminothiazoles |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006048042.2 | 2006-10-11 | ||
DE102006048042A DE102006048042A1 (en) | 2006-10-11 | 2006-10-11 | Acylaminoimidazoles and acylaminothiazoles |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008043533A2 WO2008043533A2 (en) | 2008-04-17 |
WO2008043533A3 true WO2008043533A3 (en) | 2008-07-03 |
Family
ID=39184814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/008789 WO2008043533A2 (en) | 2006-10-11 | 2007-10-10 | Acyl aminoimidazoles and acyl aminothiazoles |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2079708A2 (en) |
JP (1) | JP2010505896A (en) |
CA (1) | CA2666177A1 (en) |
DE (1) | DE102006048042A1 (en) |
WO (1) | WO2008043533A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2011003533A (en) | 2008-10-02 | 2011-06-16 | Abbott Lab | Novel compounds as calcium channel blockers. |
US8815869B2 (en) | 2010-03-18 | 2014-08-26 | Abbvie Inc. | Lactam acetamides as calcium channel blockers |
JP2015083542A (en) * | 2012-02-08 | 2015-04-30 | 大日本住友製薬株式会社 | Three substituted proline derivative |
IN2014MU00072A (en) * | 2014-01-08 | 2015-08-21 | Wockhardt Ltd | |
MA54133B1 (en) | 2018-03-08 | 2022-01-31 | Incyte Corp | Aminopyrazine diol compounds used as pi3k-y inhibitors |
WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004009565A2 (en) * | 2002-07-17 | 2004-01-29 | Sanofi-Aventis | Acylaminothiazole derivatives, preparation and therapeutic use thereof |
WO2005092864A1 (en) * | 2004-03-23 | 2005-10-06 | Pfizer Products Inc. | Imidazole compounds for the treatment of neurodegenerative disorders |
WO2007082666A1 (en) * | 2006-01-12 | 2007-07-26 | Bayer Healthcare Ag | Acylaminoimidazoles |
-
2006
- 2006-10-11 DE DE102006048042A patent/DE102006048042A1/en not_active Withdrawn
-
2007
- 2007-10-10 EP EP07818862A patent/EP2079708A2/en not_active Withdrawn
- 2007-10-10 JP JP2009531766A patent/JP2010505896A/en active Pending
- 2007-10-10 CA CA002666177A patent/CA2666177A1/en not_active Abandoned
- 2007-10-10 WO PCT/EP2007/008789 patent/WO2008043533A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004009565A2 (en) * | 2002-07-17 | 2004-01-29 | Sanofi-Aventis | Acylaminothiazole derivatives, preparation and therapeutic use thereof |
WO2005092864A1 (en) * | 2004-03-23 | 2005-10-06 | Pfizer Products Inc. | Imidazole compounds for the treatment of neurodegenerative disorders |
WO2007082666A1 (en) * | 2006-01-12 | 2007-07-26 | Bayer Healthcare Ag | Acylaminoimidazoles |
Also Published As
Publication number | Publication date |
---|---|
JP2010505896A (en) | 2010-02-25 |
CA2666177A1 (en) | 2008-04-17 |
DE102006048042A1 (en) | 2008-04-17 |
WO2008043533A2 (en) | 2008-04-17 |
EP2079708A2 (en) | 2009-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008104306A3 (en) | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | |
WO2009068214A3 (en) | Heteroaryl-substituted piperidines | |
EP2022806A4 (en) | Process for production of cross copolymers, cross copolymers obtained by the process, and use thereof | |
WO2008155069A3 (en) | Substituted oxazolidinones and use thereof | |
IL185804A0 (en) | Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments | |
WO2008113469A8 (en) | Substituted imidazopyrimidines and triazolopyrimidines | |
WO2008046581A3 (en) | Substituted tetrahydropyrrolopyrazine compounds and use thereof in medicaments | |
PT2044076E (en) | Process for the preparation of asenapine and intermediate products used in said process. | |
IL220682A0 (en) | 1h-quinazoline-2,4-diones, processes for their manufacture, and use thereof in the preparation of medicaments for treating conditions mediated by the ampa-receptor | |
WO2008060877A3 (en) | Medical devices and related methods | |
EP2096191A4 (en) | Ethylene-tetrafluoroethylene copolymer molded product and method for producing the same | |
WO2007088034A3 (en) | Tuberous sclerosis treatment | |
ZA201001015B (en) | (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
IL204556A0 (en) | (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
EP2090310A4 (en) | Method for prevention of coloration in donepezil-containing skin adhesive preparation, and method for reducing the production of donepezil analogue in donepezil-containing skin adhesive preparation | |
WO2010078900A3 (en) | Novel aliphatically substituted pyrazolopyridines, and the use thereof | |
EP2052847A4 (en) | Servo press and method of operating the same | |
PL1856988T3 (en) | Flavonoid sugar addition products, method for manufacture and use thereof | |
EP2067597A4 (en) | Embossed decorative injection-molded product and method of manufacturing the same | |
LT1928255T (en) | Method for the production of milk products, products thereby obtained, and use thereof | |
AU2007243282A8 (en) | Compositions and methods for the treatment of cardiovascular disease | |
EP2019133A4 (en) | MICROORGANISM CAPABLE OF PRODUCING gamma-L-PGA, METHOD FOR PRODUCTION OF gamma-L-PGA USING THE MICROORGANISM, CROSSLINKED PRODUCT, AND AGENT FOR EXTERNAL APPLICATION TO THE SKIN | |
WO2008043533A3 (en) | Acyl aminoimidazoles and acyl aminothiazoles | |
IL190585A0 (en) | Method for the diagnosis of thromboembolic and coronary heart diseases | |
WO2008019782A3 (en) | Dispersions of nanoureas containing active ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2007818862 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2666177 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2009531766 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07818862 Country of ref document: EP Kind code of ref document: A2 |